Homeopathic Drug Product Safety, Quality, and Transparency Act
Referred to the House Committee on Energy and Commerce.
Email me when HR 7050 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track HR 7050. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The bill amends the Federal Food, Drug, and Cosmetic Act to create a separate statutory pathway for homeopathic drug products, defining them, setting manufacturing and labeling standards, and limiting FDA pre‑market approval. It affects manufacturers, consumers and regulators by requiring compliance with the Homeopathic Pharmacopoeia or accredited consensus standards, and by creating an advisory committee to guide implementation. The measure seeks to ensure product safety while preserving consumer access to homeopathic medicines.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about HR 7050
3 free questions a day, no accountHistory
- Referred to the House Committee on Energy and Commerce.
- Introduced in House
Sponsors
- Rep. Sessions, Pete [R-TX-17] (R) · sponsor
- Rep. Jackson, Jonathan L. [D-IL-1] (D)
- Rep. Kennedy, Mike [R-UT-3] (R)
- Rep. Mills, Cory [R-FL-7] (R)
- Rep. Owens, Burgess [R-UT-4] (R)
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HR 7050 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HR 7050 freeOr ask your AI assistant about HR 7050 directly:
Add to Claude, ChatGPT or Cursor